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INTRODUCTION
Decreasing physical activity and rising 
obesity are major global public health issues. 
Physical inactivity is a primary risk factor for 
obesity, diabetes mellitus,1 and a major cause 
of premature death from cardiovascular 
disease,2,3 cancer,4 and other chronic 
diseases.5,6 Although numerous studies 
have shown than even modest increases 
in physical activity are associated with a 
reduction in cardiovascular3 and all-cause 
mortality,7 the World Health Organization 
reports that obesity rates have doubled since 
1980;8 while this is occurring, rates of physical 
activity are continuing to decline.9
For interventions to effectively increase 
physical activity, they need to:
• motivate people to undertake a change in 
behaviour;10
• offer realistic goal setting,11 which can be 
in conjunction with a primary care health 
professional;12 and
• provide regular feedback on activity rates, 
such as provided by a pedometer.13
Such interventions can significantly 
increase physical activity,14 but changes 
are usually not sustained.10 Pedometers 
have additional disadvantages, such as 
the need for individuals to carry an extra 
piece of purchased technology and the 
instrument’s limited memory and feedback 
capability. Smartphone applications (apps), 
on the other hand, provide solutions to 
many of these limitations and, in addition, 
have added functionality that may be 
useful in the promotion of physical activity 
via third-generation ‘computer-tailored’ 
interventions.15 As a potential population-
based intervention, apps are very attractive, 
as 90% of mobile phone users in the US are 
in possession of their telephone 24-hours 
a day.16 This randomised controlled trial 
(RCT) aimed to evaluate the effectiveness 
of a smartphone app in increasing physical 
activity in primary care.
METHOD
Participant recruitment
The SMART MOVE intervention featured an 
open-label, RCT of a smartphone app to 
promote physical activity in primary care. 
The study took place in the west of Ireland, 
with participants recruited and followed up 
through three primary care centres that 
make up the North Clare Primary Care 
Team; a rural primary care team covering 
an economically diverse, but predominantly 
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Abstract
Background 
Physical inactivity is a major, potentially modifiable, 
risk factor for cardiovascular disease, cancer, 
and other chronic diseases. Effective, simple, 
and generalisable interventions that will increase 
physical activity in populations are needed.
Aim
To evaluate the effectiveness of a smartphone 
application (app) to increase physical activity in 
primary care.
Design and setting
An 8-week, open-label, randomised controlled 
trial in rural, primary care in the west of Ireland. 
Method
Android smartphone users >16 years of age were 
recruited. All participants were provided with 
similar physical activity goals and information 
on the benefits of exercise. The intervention 
group was provided with a smartphone app and 
detailed instructions on how to use it to achieve 
these goals. The primary outcome was change in 
physical activity, as measured by a daily step count 
between baseline and follow-up.
Results
A total of 139 patients were referred by their 
primary care health professional or self-referred. 
In total, 37 (27%) were screened out and 12 (9%) 
declined to participate, leaving 90 (65%) patients 
who were randomised. Of these, 78 provided 
baseline data (intervention = 37; control = 41) 
and 77 provided outcome data (intervention = 37; 
control = 40). The mean daily step count at 
baseline for intervention and control groups was 
4365 and 5138 steps per day respectively. After 
adjusting, there was evidence of a significant 
treatment effect (P = 0.009); the difference in mean 
improvement in daily step count from week 1 
to week 8 inclusive was 1029 (95% confidence 
interval 214 to 1843) steps per day, favouring the 
intervention. Improvements in physical activity in 
the intervention group were sustained until the 
end of the trial.
Conclusion
A simple smartphone app significantly increased 
physical activity over 8 weeks in a primary care 
population.
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white, population of approximately 8000 
individuals.17 
Enrolment into the study commenced 
on 15 August 2012 and all final outcome 
assessments were completed by 1 June 
2013. The full study protocol has been 
published elsewhere18 and the study was 
carried out without any deviations from 
the protocol. Patients were eligible for the 
study if they were over the age of 16 years 
and active Android smartphone users; 
patients were excluded if they: 
• did not have an Android smartphone; 
• had an acute psychiatric illness; 
• were pregnant; or 
• could not undertake moderate exercise (for 
any reason including being overweight).
Multiple methods were used to recruit 
potential participants, including referral by 
their primary care health professional or 
self-referral in response to primary care 
centre and community advertisements or 
mailshots. 
Randomisation and intervention
At the first contact (face-to-face or 
telephone), information about the study 
was provided to potential participants and 
they were invited to attend a preliminary 
screening meeting with the study 
investigators at their nearest primary care 
centre. If eligible, informed consent was 
obtained and participants were assigned 
a code. Randomisation occurred using 
random permuted blocks to ensure there 
were similar numbers of participants in 
the intervention and control groups. An 
independent investigator was responsible 
for generating the allocation sequence 
using the Research Randomizer computer 
software program (available at www.
randomizer.org/form.htm) The same 
independent investigator was responsible 
for assigning participants to the intervention 
and control groups after being called at a 
central site. 
After the randomisation code was 
assigned, baseline screening was conducted 
blinded, during which relevant clinical, 
anthropometric, psychological, and mobile-
device data were collected. All participants 
then had the smartphone app downloaded 
onto their mobile phone to record their daily 
step count in order to provide a measurement 
of their baseline physical activity levels. The 
app provided automatic feedback and 
tracking of the step count and calories 
burned, and a visually appealing display of 
step count history and goal achievement. 
A 20-step test19 was carried out with each 
participant to calibrate the sensitivity level 
of the telephone for different individuals to 
ensure their step count would be recorded 
accurately. For the week following the 
screening visit (week 1), all participants 
were asked to carry their smartphone during 
waking hours and to continue operating at 
their normal physical activity levels. During 
week 1, the smartphone app display was not 
visible for either group and the investigators 
remained blinded.
At the end of week 1, the randomisation 
code was broken by the investigators. In this 
way, the allocation sequence was concealed 
from all study investigators and participants 
until all codes were assigned and week 1 
was completed. Both intervention and 
control groups were then given similar 
physical activity goals and information on 
the benefits of exercise; however, only the 
intervention group was told how to use the 
app to help them achieve these goals. All 
participants were also issued with the Irish 
Heart Foundation Be Active physical activity 
promotion brochure20 by post or email and 
were instructed to keep their telephone 
charged and to always carry it during waking 
hours. 
Those assigned to the intervention group 
were contacted by telephone at the end 
of week 1 and were told how to turn on 
the app’s display and about the usability 
features of the app’s settings and feedback. 
They were encouraged to interact with the 
smartphone app and were given a physical 
activity goal of 10 000 steps per day. Those 
assigned to the control group were also 
contacted by telephone at the end of week 
1 and were given a physical activity goal of 
walking for 30 minutes per day in addition 
How this fits in
Numerous studies have shown that 
even modest increases in physical 
activity are associated with reductions in 
cardiovascular and all-cause mortality, 
as well as contributing to primary and 
secondary prevention of several chronic 
diseases. Despite this, obesity rates have 
doubled since 1980, with rates of physical 
activity continuing to decline. Effective, 
simple, and generalisable interventions 
are needed in primary care and this study 
demonstrates that use of a smartphone 
application can increase physical activity by 
over a 1000 steps a day. Such inexpensive, 
widely available, and user-friendly 
technologies should be considered as 
a component of future interventions to 
promote physical activity.
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to their normal activity (the equivalent of 
10 000 steps).21 
At the end of weeks 1, 2, and 8, all 
participants were contacted via SMS and 
asked to email their step-count data to the 
research team using a ‘share data’ function 
of the app. All participants were invited 
back for follow-up testing within 1 week of 
finishing the trial.
Smartphone app and selection process
Smartphone apps are software applications 
designed to run on smartphones. The 
Accupedo-Pro Pedometer app (available 
at www.accupedo.com) was chosen for the 
study as it scored highest during a selection 
process using already-established desired 
criteria for smartphone apps promoting 
physical activity.22 These criteria included: 
• automatic feedback and tracking of step 
count and calories burnt; 
• visually appealing graphic display of 
step-count history; and 
• goal setting functionality and goal-
achievement feedback.
Outcomes
The primary outcome measure was 
difference in mean daily step count 
between baseline (week 1) and follow-
up (weeks 2–8). Step-count data were 
recorded automatically, beyond the 
control of investigators and participants, 
and stored by the app on the telephones 
of all trial participants. Seven secondary 
outcomes were measured at baseline and 
at the end of the follow-up period: 
• mean systolic blood pressure; 
• mean diastolic blood pressure; 
• mean resting heart rate; 
• weight and body mass index (BMI); 
• mental health, as measured by the 
Hospital Anxiety and Depression Scale 
(HADS);
• quality of life, as measured by EuroQol 
(EQ)-5D; and 
• quality of life, as measured by EQ-VAS 
(EQ, visual analogue scale). 
The recording of mean systolic blood 
pressure and mean diastolic blood pressure 
was carried out by a specifically trained 
research nurse using the current British 
Hypertension Society guidelines (available 
at www.bhsoc.org/latest-guidelines/
how-to-measure-blood-pressure) and 
independently validated devices (Omron 
I-C10 if arm circumference was ≤17 inches 
or Omron R7 if arm circumference was >17 
inches.23 
Sample size 
The required sample size was based on 
previous pilot work and calculated by taking 
into account the following assumptions: 
• individuals had an estimated mean daily 
step count at baseline of 4700 steps;
• there would be a 10% reduction in the 
daily step count in the control group over 
the trial period; 
• the standard deviation (SD) of mean 
change in step count would be 2000 
steps; 
• it would be possible to detect a relative 
increase of at least 20% in the change 
of the average step count between the 
intervention and control groups, with 80% 
power at a significance level of 0.05; and 
• there would be a drop-out rate of 15%. 
Based on these considerations, 
approximately 40 participants per group 
were required. 
Statistical analysis
Baseline data were summarised across 
the two arms using suitable numerical 
summaries and graphical techniques. For 
the primary outcome, the mean change 
in step count from week 1 to week 8 was 
compared between the intervention and 
control groups (unadjusted and adjusted). 
For the adjusted analysis (primary analysis), 
a generalised, additive, mixed model was 
used and explanatory variables identified 
a priori.18 The model was adjusted for 
the non-linear relationship that was 
evident between the primary outcome 
and time, the correlation within subject 
over time, baseline step count, age, sex, 
socioeconomic status, BMI, blood pressure, 
heart resting rate, mental health, quality of 
life, and smartphone literacy. 
Analysis of missing data suggested 
they were missing at random and were, 
therefore, accounted for in the mixed 
model; the validity of this assumption was 
investigated by looking at the missing-
data patterns and by modelling the 
probability of missing data based on the 
explanatory variables available. Model 
checking was performed using suitable 
model diagnostics and residual plots. All 
statistical analyses were performed using 
the software packages SPSS (version 21.0 
R version 2.14.3), R libraries nlme, mgcv, 
and ggplot 2. 
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RESULTS
Participants’ recruitment and baseline 
characteristics
A total of 139 potential participants were 
referred by their primary care health 
professional or self-referred to the study. Of 
these, 49 (35%) were excluded, mainly due 
to not having the correct mobile device; as 
a result, 90 were eligible and randomised 
(Figure 1). Those randomised had a mean 
age of 44.1 (+/–11.5) years, a mean BMI 
of 28.2 (+/–5.5) and 58 (64%) were female. 
Other baseline clinical characteristics are 
outlined in Table 1. 
There were no significant differences 
between control and intervention groups at 
baseline except for sex (P = 0.008) and one 
measure of quality of life (EQ-5D, P = 0.03). 
Both these differences were addressed by 
the a priori decision to adjust for these 
covariates, among others, in the analyses. 
Of the 90 participants randomised, 77 (86%) 
completed follow-up; most loss to follow-up 
occurred during baseline week (Figure 1). 
Outcome data
A non-linear effect of time is evident in 
plots of the daily step count. Figures 2a 
and 2b illustrate daily and smoothed mean 
steps (with 95% confidence interval [CI] 
for cubic spline smoother) for the step 
data when using a log (to the base 10) 
for ease of interpretation. The unadjusted 
mean difference (and SD) in improvement 
in step count between week 1 and week 
8 for the control and intervention groups 
was –386 (SD = 3281) and 1631 (SD = 3842) 
steps, respectively (Table 2 and Figure 3), 
which is a difference in mean improvement 
of 2017 (95% CI = 265 to 3768) steps per day, 
favouring the intervention. 
Changes between baseline and follow-
up for control and intervention groups for 
all primary and secondary outcomes are 
outlined in Table 2. No significant changes 
were observed for secondary outcomes of 
systolic blood pressure (+3.8mmHg versus 
–0.6mmHg), diastolic blood pressure 
(+0.9mmHg versus –0.9mmHg), weight 
(–0.16kg versus –0.33kg), and BMI (–0.06kg/
[height in m2] versus –0.12kg/[height in m2]), 
although point estimates all favoured the 
intervention group. 
After adjusting for possible explanatory 
variables, there was still evidence of a 
significant treatment effect (P = 0.009), 
where the difference in mean improvement 
in mean daily step count from week 1 
to week 8 inclusive was 1029 (95% CI 
214 to 1843) steps per day favouring the 
intervention. 
Given that the mean daily step count 
during week 1 was 4771, a difference 
in improvement of 1029 steps per day 
is approximately a 22% (95% CI = 5 to 
39) increase in physical activity, relative 
to baseline. There was evidence that the 
treatment effect was maintained at 8 weeks 
in the intervention group only (Figure 2).
DISCUSSION
Summary
The use of a smartphone app was found to 
increase physical activity over an 8-week 
period, when compared with data from the 
control group. The magnitude of change 
(over 1000 steps per day or approximately 
half a mile) is clinically meaningful and, 
if continued, is expected to result in long-
term health benefits such as reduced 
cardiovascular and diabetes risk. 
Although the control group demonstrated 
an initial increase in physical activity, this 
was followed by a decrease to baseline 
activity by the end of the trial period; the 
increase in activity seen in the intervention 
group, however, was maintained. 
Assessed for eligibility
(n = 139)
Randomised (n = 90)
Allocated to intervention (n = 45):
 Received allocated intervention (n = 37)
 Did not receive allocated intervention
  (n = 8):
 •   Did not carry phone  (n = 1)
 •   Excess battery drainage (n = 5)
 •   Withdrew  (n = 2)
Lost to follow-up (opted out) (n = 0) Lost to follow-up (opted out) (n = 1)
Analysed (n = 37) Analysed (n = 40)
Allocated to control (n = 45):
 Received allocated intervention (n = 41)
 Did not receive allocated intervention
  (n = 4):
 •   Application killera (n = 1)
 •   Application malfunction (n = 1)
 •   Excess battery drainage (n = 1)
 •   Withdrew  (n = 1)
          Excluded (n = 49)
Not meeting inclusion criteria
                     (n = 37)
• iPhone (n = 21)
• Non-smartphone (n = 14)
• Blackberry (n = 2)
Figure 1. Participant recruitment and follow-up. 
aApplication killer is a piece of software present on some smartphones that can restrict the automatic 
functions of smartphone applications.
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Strengths and limitations 
The strengths of this study are the 
randomised design, the high completion 
rate for participants (86%) and the limited 
number of exclusion criteria. The relatively 
small number of potential participants 
that were excluded should strengthen 
the external validity24 of the results and 
may help to facilitate implementation, 
particularly with such an open recruitment 
strategy.
However, this study also had a number 
of limitations. The study was small and 
conducted in a single country in a white 
population with short follow-up. The 
relatively small sample size makes the 
study more vulnerable to a failure of 
randomisation, which the researchers 
sought to correct by using a multivariable 
analysis with explanatory variables 
identified a priori.18 The sample size also 
meant the study was underpowered to 
detect significant differences in the 
secondary outcomes.
In addition, there was a difference in 
baseline step count between control 
and intervention groups. This was not 
statistically significant but, nonetheless, 
this potential difference was recognised a 
priori and adjusted for in the final statistical 
Table 1. Participants’ baseline characteristics.
 Control group, n = 45a Intervention group, n = 45b Total, n = 90
Age in years, mean (SD)  46 (11) 42 (11) 44 (11)
Female, n (%)c  23 (51) 35 (78) 58 (64)
Male, n (%)  22 (49) 10 (22) 32 (36)
Medical card eligibility, mean (SD)d 14 (58)  10 (42) 24 (27)
 Referred by health professional, n (%) 35 (78) 33 (73) 68 (76)
 Self-referred, n (%) 10 (22) 12 (27) 22 (24)
 Systolic blood pressure, mmHg, mean (SD) 124.3 (13.6) 121.8 (16.1) 123.1 (14.9)
 Diastolic blood pressure, mmHg, mean (SD) 81.3 (7.3) 81.4 (9.1) 81.3 (8.2)
 Resting heart rate, beats per minute, mean (SD) 71.4 (8.4) 73.8 (9.9) 72.6 (9.2)
 Weight in kg, mean (SD) 86.7 (18.7) 78.6 (22.1) 82.6 (20.7)
 BMI, mean (SD) 28.9 (4.9) 27.4 (6.0) 28.2 (5.5)
 HADS, mean (SD) 4.0 (3.2) 3.5 (2.5) 3.7 ()2.9)
 EQ-VAS, mean (SD) 73.2 (18.4) 74.1 (16.3) 73.7 (17.3)
 EQ-5D, mean (SD)e 0.83 (0.10) 0.87 (0.07) 0.85 (0.09)
 Email on mobile phone, n (%) 36 (80) 33 (73) 69 (77)
 Smartphone apps previously downloaded, n (%) 8 (18) 9 (20) 17 (19)
 Baseline daily step count, mean (SD) 5138 (3873) 4365 (2732) 4771 (3380)
aIn control group, n = 41 for baseline step count, n = 44 for HADS, and n = 43 for EQ-VAS. bIn intervention group, n = 37 for baseline step count, and n = 42 for EQ-VAS. P>0.05 
for all comparisons except: csex (P = 0.008) and eEQ-5D (P = 0.03). dSocioeconomic status was measured at the individual level by whether participants were ‘medical card 
eligible’, a means-tested health benefits scheme. BMI = body mass index. EQ-VAS = EuroQol visual analogue scale quality-of-life scoring tool. HADS = Hospital Anxiety and 
Depression Scale. SD = standard deviation.
Figure 2. Daily step count with smoothed mean steps 




















































b) Plot of daily steps with
smoother (log scale)
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model. Participants in the control-group 
were not given instructions on how to use 
the app and its display was not made 
visible on their telephones; however, they 
were aware that the app was running in 
the background, monitoring their daily 
activity. An experienced smartphone user 
in the control group could have accessed 
the app and, therefore, benefited from 
interaction with it, but this would decrease 
the likelihood of there being any difference 
between the groups. Alternatively, it is 
possible this awareness in the control 
group could have had a paradoxical effect 
on their motivation and physical activity. 
Finally, due to the ‘sleep’ function on 
certain smartphone models, which forced 
the app to pause, some step-count data 
were not recorded’ this is why such data 
were not available for all participants at 
follow-up. However, this was similar for 
both groups over the course of the trial 
and was accounted for in the statistical 
modelling.
Comparison with existing literature
The SMART MOVE intervention shares 
the basic features and accuracy of 
pedometer-based interventions, which 
are associated with increases in physical 
activity of approximately 500–3500 steps 
per day, as well as significant decreases 
in BMI and blood pressure.14 A similar 
intervention effect size was reported here, 
but without the burden of cost associated 
with a pedometer purchase or the need for 
individuals to remember to carry this extra 
piece of equipment. The improvements 
in physical activity that have been seen 
when individuals use pedometers and other 
interventions are often not sustained and, 
indeed, appear to decrease with time.10 This 
is, in part, due to the fact that the practice of 
carrying the pedometer wanes with time,25 
particularly among younger (>20 years) age 
groups.26 
The advantage of using a smartphone 
app is that no additional instrument is 
required as people generally carry their 
mobile phones with them continuously. 
This in itself however, may not be sufficient 
to guarantee ongoing engagement with 
the app. Additional features may help such 
as feedback on time, speed, and energy 
consumption metrics, accompanied by 
attractive user-friendly graphic displays 
and a system of rewards for goals achieved. 
These features provide smartphone apps 
with significant potential as third-generation 
‘tailored’ interventions that can be used to 
promote physical activity in particular. 
A growing body of evidence shows that 
behaviour-change programmes using 
computer tailoring can be effective in 
changing lifestyle risk factors, such as 
physical activity.15 The emerging field of 



















Figure 3. 8-week improvement in mean steps in 
control and intervention groups.
Table 2. Mean differences for outcomes in control and intervention 
groups. 
  Week 1,   Week 8,  Mean difference  
Primary outcome n mean (SD) n mean (SD) (SD) P-value
Step count
 Control group 41 5138 (3873) 35 4859 (3474) –386 (3281) 0.025a
 Intervention group 37 4365 (2732) 31 5855 (4264) 1631 (3842)
  Baseline,   Follow-up,  Mean difference   
Secondary outcomes n mean (SD) n mean (SD) (SD) P-value
Systolic blood pressure, mmHg
 Control group 45 124.3 (13.6) 40 128.7 (14.7) 3.8 (12.4) 0.117
 Intervention group 45 121.8 (16.1) 37 120.6 (17.2) –0.6 (11.8)
Diastolic blood pressure, mmHg
 Control group  45 81.3 (7.3) 40 82.4 (9.5) 0.90 (8.0) 0.376
 Intervention group 45 81.4 (9.1) 37 80.0 (10.3) –0.88 (9.5)
Resting heart rat, beats per minute
 Control group 45 71.4 (8.4) 38 68.1 (6.5) –3.0 (8.0) 0.213
 Intervention group 45 73.8 (9.9) 36  72.1 (10.1) –0.4 (10.0)
Weight, kg
 Control group 45 86.7 (18.7) 39 85.2(18.7) –0.16 (2.3) 0.738
 Intervention group 45 78.6 (22.1) 37 76.4(21.6) –0.33 (1.9)
BMI
 Control group 45 28.9 (4.9) 39 28.7 (4.8) –0.06 (0.8) 0.738
 Intervention group 45 27.5 (6.1) 37 26.7 (5.6) –0.12 (0.7)
HADS
 Control group  44 4.0 (3.2) 39  2.3 (2.2) –1.7 (2.9) 0.917
 Intervention group 45 3.5 (2.5) 37  2.0 (1.9) –1.6 (2.3)
EQ-VAS
 Control group 43 73.2 (18.4) 38 81.8 (11.7) 7.9 (12.1) 0.791
 Intervention group 42 74.1 (16.3) 37 79.6 (17.7) 7.0 (14.9)
EQ-5D
 Control group 45 0.83 (0.10) 37 0.88 (0.07) 0.04 (0.10) 0.148
 Intervention group 45 0.87 (0.07) 36 0.88 (0.07) 0.01 (0.05)
aThe adjusted P-value for week 1 to week 8 inclusive was P = 0.009. BMI = body mass index. EQ-VAS = EuroQol 
visual analogue scale quality-of-life scoring tool. HADS = Hospital Anxiety and Depression Scale. SD = standard 
deviation.
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captology — the study of computers as 
persuasive technology — has described 
many of the mechanisms by which mobile 
phones have become such an important 
platform for changing human behaviour.27 
Implications for practice
It has been suggested that significant 
improvements in public health in the 
future are more likely to come from 
behavioural change, rather than from 
technological or scientific innovation.28 
The results of this current study would 
suggest that novel technologies, such as 
mobile devices and related smartphone 
apps, may become an important driver for 
the behavioural-change process. Rather 
than just providing more evidence that 
tracking in any form supports behaviour 
change, this trial represents an important 
step forward in the challenging issue of 
physical activity promotion. However, larger 
RCTs with longer follow-up are required to 
examine long-term sustainability of such 
improvements. Further data with longer 
follow-up using the smartphone app from 
the current trial is being compiled across 
six European countries.29 
The exponential rise in global 
smartphone use in the past 5 years means 
that accessibility to such technologies is 
now the norm rather than the exception: 
in Ireland, 57% of mobile telephone 
customers possess a smartphone,30 while 
this number is greater than 60% in the 
US.31 Smartphone use is set to continue 
to increase rapidly as non-smartphone 
upgrades will be increasingly rare in the 
future.32 Meanwhile, the number of health-
related smartphone apps available is over 
13 000 and rising, of which 16% are exercise 
related.33 
Several previous studies have used 
the SMS capability of mobile phones 
and smartphones in intervention and 
observational studies but the capability of 
smartphone apps themselves in research 
has rarely been exploited.34
The rapid penetration of smartphones 
throughout society and the ready availability 
of multiple apps promoting physical activity 
represent a unique opportunity in population 
health to use these devices to explore, 
understand, and positively change human 
behaviour. Such inexpensive, accessible, 
and user-friendly technologies should be 
considered a component of any future 
intervention to promote physical activity in 
primary care.
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